Post-doctoral fellow in immunology (F/M)

Institut Curie; Paris; Sur place; EUR 38 000 - 48 000; Plein temps

Résumé du poste

The post-doctoral fellow will join Dr Eliane Piaggio's research group (Inserm U932) on the Institut Curie campus in central Paris, as part of an immunology department of 130 people headed by Dr Ana-Maria Lennon. The laboratory is located on the Institut Curie campus in central Paris.

The team comprises 13 members, including two bioinformaticians and a project manager. The post-doctoral fellow's mission will be to achieve a project in translational immunology research related to the involvement

Qualifications

• Post-doctoral fellow in translational immunology focusing on regulatory T cells in cancer.
• Responsible for development, handling and analysis of experiments and bibliography monitoring.

Responsabilités

• Execute translational immunology projects under supervision.
• Develop, handle and analyze experiments; monitor relevant literature.

Connaissances

Immunology

Experiment design

Literature review

Description du poste

Laboratory

Dr Eliane Piaggio's research group (Inserm U932, Paris, France, https://institut-curie.org/team/piaggio) is part of an immunology department of 130 people headed by Dr Ana-Maria Lennon. The laboratory is located on the Institut Curie campus in central Paris. The building is equipped with state-of-the-art facilities (imaging, proteomics, animal facilities, genomic and cytometric platforms). The Institute is home to some 1,500 scientists, including many foreign students and post-docs.

The team comprises 13 members, including two bioinformaticians and a project manager.

Missions

The post-doctoral fellow's mission will be to achieve a project in translational immunology research related to the involvement of T regulatory lymphocytes in cancer. The candidate will be responsible for the development, handling and analysis of experiments, and for monitoring the bibliography. Projects will be developed under the supervision of Dr Eliane Piaggio.f cancers as part of the continuum between basic research and innovation serving the patient.